Paul Hérbert

Dr. Paul Hébert was appointed President of the Canadian Institutes of Health Research (CIHR) on January 2, 2025. An Acadian clinician-scientist and health leader, he is a professor of medicine at the University of Ottawa and a practicing palliative care physician, with a background in critical care. He is internationally recognized for his research in resuscitation and transfusion medicine, particularly the landmark TRICC trial published in the New England Journal of Medicine in 1999. His research spans critical care, palliative care, aging and long-term care, with more than $65 million in research funding and over 480 peer-reviewed publications. Dr. Hébert has held numerous leadership roles, including Editor-in-Chief of the Canadian Medical Association Journal, Chair of the Canadian Critical Care Trials Group, Chief Medical and Science Officer of the Canadian Red Cross, and Scientific Director of Ontario’s Public Health Emergency Taskforce. He is a Fellow of the Canadian Academy of Health Sciences and has received several career awards, including the Landsteiner-Alter Award for his contributions to transfusion medicine.